We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Oncology

Journal Scan / Research · June 11, 2020

Time From Diagnosis to Treatment Does Not Affect the Prognosis of Patients With Newly Diagnosed AML

Blood

 

Additional Info

Disclosure statements are available on the authors' profiles:

Blood
Does Time From Diagnosis to Treatment Affect the Prognosis of Patients With Newly Diagnosed Acute Myeloid Leukemia?
Blood 2020 Jun 04;[EPub Ahead of Print], C Röllig, M Kramer, C Schliemann, et al

Further Reading